Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler
Clinical trial NCT01213849 · COMPLETED
Trial details
- NCT number
- NCT01213849
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-04
- Primary completion
- 2010-11-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.